ARCHIVES

Review Of Organ Site Program Requested By NCAB Set For Nov. 23-25; Eight Member Committee Named

This article is from The Cancer Letter archive.

Vol. 07 No. 34 | August 21, 1981

Download PDF Visit The Full Archive

Related Articles

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001

FDA Orders More Changes In ESA Label,

August 8, 2008

NCI awards $42 million for prevention trials consortium.

December 5, 2003

Also in this 8-page issue: Intel Chairman Andrew Grove slams NCI director and cancer program for “wishful dreams” and “chemo speeches,” recommends moratorium on funding for cancer research.

May 14, 2004

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz

March 29, 2013